BLOSSOMHILL THERAPEUTICS
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.
BLOSSOMHILL THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.bhtherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
71 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Cytocom
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
KeChow Pharma
KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.
Monopar
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
XinThera
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Current Advisors List
Board_member
Board_member
2020-07-01
Board_member
Board_member
Current Employees Featured
Y. Peter Li Co-Founder @ BlossomHill Therapeutics
Co-Founder
2020-07-01
J. Jean Cui Co-Founder, President, and CEO @ BlossomHill Therapeutics
Co-Founder, President, and CEO
Founder
Investors List
Hercules Bioventure Partners
Hercules Bioventure Partners investment in Series A - BlossomHill Therapeutics
OrbiMed
OrbiMed investment in Series A - BlossomHill Therapeutics
Vivo Capital
Vivo Capital investment in Series A - BlossomHill Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series A - BlossomHill Therapeutics
Official Site Inspections
http://www.bhtherapeutics.com
Unable to get host informations!!!
More informations about "BlossomHill Therapeutics"
About | BlossomHill Therapeutics
May 29, 2024 Dr. J. Jean Cui has a prolific track record as a cancer drug designer and developer. Three molecules designed by Dr. Cui have become …See details»
BlossomHill Therapeutics - Crunchbase Company …
Contact Email info@bhtherapeutics.com BlossomHill Therapeutics, Inc. is a …See details»
BlossomHill Therapeutics, Inc.’s Post - LinkedIn
#ICYMI: Our President and CEO, Dr. J. Jean Cui, was recently elected to the National Academy of Engineering (NAE) for her innovation of new medicines to fight cancers and address urgent …See details»
BlossomHill Therapeutics - VentureRadar
MtoZ Biolabs USA Privately Held MtoZ Biolabs is an international contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical …See details»
Blossomhill Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
BH-30643 is a macrocyclic, mutant selective OMNI-EGFR™ inhibitor with sub-nanomolar potency against classical and atypical EGFR mutations that is maintained even in the presence of …See details»
Blossomhill Therapeutics, Inc. (Blossomhill Therapeutics, Inc.) - 药 …
May 7, 2025 Headquartered in San Diego, California, BlossomHill Therapeutics is supported by a strong syndicate of leading investors, including Cormorant Asset Management, OrbiMed, …See details»
BlossomHill Therapeutics, Inc. | The Work Index by Flexa
BlossomHill Therapeutics emphasizes a culture that values human intelligence, creative thinking, and a track record of drug design expertise. They believe in a diverse team with a science …See details»
Company Information - RocketReach
BlossomHill Therapeutics, Inc. employs 44 employees. The BlossomHill Therapeutics, Inc. management team includes J Cui (Scientific Founder, President and CEO), Vince Liptak …See details»
Blossomhill Therapeutics - Overview, News & Similar ... - ZoomInfo
Blossomhill Therapeutics contact info: Phone number: (858) 732-3880 Website: www.bhtherapeutics.com What does Blossomhill Therapeutics do? Blossomhill Therapeutics …See details»
Home | BlossomHill Therapeutics
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you …See details»
BlossomHill Therapeutics Closes $71M Series A Financing
SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a biopharmaceutical company focusing on oncology and autoimmune disorders, announced …See details»
BlossomHill Therapeutics
BlossomHill Therapeutics is developing small molecule therapeutics for unmet medical needs in oncology and autoimmune diseases. Founded by renowned drug design and development …See details»
Careers | BlossomHill Therapeutics
We are a science-forward organization led by our luminary, Dr. Jean Cui, and we welcome all to traverse mountains, ridges, rivers and streams to BlossomHill and solve treatment resistance. …See details»
Blossom Therapeutics (Blossom Therapeutics) - 药物管线_专利_临 …
May 7, 2025 Headquartered in San Diego, California, BlossomHill Therapeutics is supported by a strong syndicate of leading investors, including Cormorant Asset Management, OrbiMed, …See details»
Science | BlossomHill Therapeutics
Despite significant advances in cancer therapy and precision medicine, cures remain elusive due to cancer’s remarkable ability to develop tolerance and resistance to treatments, one of the …See details»
BHB Therapeutics - VentureRadar
BHB Therapeutics is based on research conducted in the labs of Eric Verdin, MD and John Newman, MD, PhD. The work centers on the emerging signalling functions of a metabolite …See details»
BH-30236 - Drug Targets, Indications, Patents - Synapse
May 7, 2025 BH-30236: a CLK1 inhibitors, CLK2 inhibitors, CLK4 inhibitors Drug, Initially developed by Blossomhill Therapeutics, Inc., Now, its global highest R&D status is Phase 1, …See details»
BIO Announces Dedicated Focus on Human Health and …
1 day ago Washington, DC, May 28, 2025 – The Biotechnology Innovation Organization (BIO) today announced plans to dedicate its focus entirely to human health and to transition the work …See details»
Pipeline | BlossomHill Therapeutics
We are evaluating a potentially better way to treat EGFR-positive NSCLC. BH-30643 is a mutant-selective OMNI-EGFR ™ inhibitor with an aim to provide greater benefit to patients by:. Super …See details»
Terms of Service | BlossomHill Therapeutics
You have the right to opt-out and not be bound by the arbitration provisions set forth in these Terms by sending written notice of your decision to opt-out to info@bhtherapeutics.com. The …See details»